Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry

Clinical Chemistry

Volumn 51, Issue 3, 2005, Pages 586-592

  Brown, Nigel W ^a   Gonde, Christopher E ^a   Adams, Jemimah E ^a   Tredger, J Michael ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN; TACROLIMUS;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; HEMATOCRIT; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LIQUID CHROMATOGRAPHY; LIVER GRAFT; MICROPARTICLE ENZYME IMMUNOASSAY; PANCREAS ISLET; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHROMATOGRAPHY, LIQUID; FALSE POSITIVE REACTIONS; HEMATOCRIT; HEPATOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MASS SPECTROMETRY; PARTICLE SIZE; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; TACROLIMUS;

EID: 14544287267     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.043950     Document Type: Article

References (25)

1. O'Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial. Lancet 2002;360:1119-25.
2. Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, et al. Results of LIS2T, a multicentre, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with CO monitoring in de novo liver transplantation. Transplantation 2004;77:1632-8.
3. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, Bustami RT, Dyke DB. Immunosuppression: practice and trends. Am J Transplant 2004;4:38-53.
4. Tredger JM, Gilkes CD, Gonde CE. Therapeutic monitoring of tacrolimus (FK506) with the first and second-generation microparticle enzyme immunoassays: performance and results in four patient populations. Ther Drug Monit 1998;20:266-75.
5. Schambeck CM, Bedel A, Keller F. Limit of quantification (functional sensitivity) of the new IMx tacrolimus II microparticle enzyme immunoassay. Clin Chem 1998;44:2217.
6. Ghoshal AK, Soldin SJ. IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MS. Clin Biochem 2002;35:389-92.
7. Salm P, Taylor PJ, Clark A, Balderson GA, Grygotis A, Norris RLG, et al. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants. Ther Drug Monit 1997;19:694-700.
8. Zhang Q, Simpson J, Aboleneen HI. A specific method for measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry. Ther Drug Monit 1997;19:470-6.
9. Keevil BG, McCann SJ, Cooper DP, Morris MR. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem 2002;39:487-92.
10. Kuzuya T, Ogura Y, Motegi Y, Moriyama N, Nabeshima T. Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay. Ther Drug Monit 2002;24:507-11.
11. Homma M, Tomita T, Yuzawa K, Takada Y, Ibaraki K. False positive blood tacrolimus concentration in microparticle enzyme immunoassay. Biol Pharm Bull 2002;25:1119-20.
12. Analytical Services International, Ltd. International proficiency testing scheme for tacrolimus. http://www.bioanalytics.co.uk/html/tacrolimus_scheme. html/ (accessed November 2004).
13. Cogill JL, Taylor PJ, Westley IS, Morris RG, Lynch SV, Johnson AG. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998;44:1942-6.
14. Armstrong VW, Shütz E, Zhang Q, Groothuisen S, Scholz C, Shipkova M, et al. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II). Clin Chem 1998; 44:2516-23.
15. Taylor PJ, Morris RG. Tacrolimus measurement by microparticle enzyme immunoassay II. Ther Drug Monit 2003;25:259-60.
16. Chow F-S, Piekoszewski W, Jusko WJ. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab Dispos 1997;25:610-6.
17. Spencer CM, Goa KL, Gillis JC. Tacrolimus: an update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997;54:925-75.
18. Piekoszewski W, Jusko WJ. Plasma protein binding of tacrolimus in humans. J Pharm Sci 1993;82:340-1.
19. Iwasaki K, Shiraga T, Matsuda H, Nagase K, Tokuma Y, Hata T, et al. Further metabolism of FK506 (tacrolimus): identification and biological activities of the metabolites oxidized at multiple sites of FK506. Drug Metab Dispos 1995;23:28-34.
20. Tamura K, Fujimura T, Iwasaki K, Sakuma S, Fujitsu T, Nakamura K, et al. Interaction of tacrolimus (FK506) and its metabolites with FKBP and calcineurin. Biochem Biophys Res Commun 1994;202:437-43.
21. Alak AM. Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies. Ther Drug Monit 1997;19:338-51.
22. Murthy JN, Davis DL, Yatscoff RW, Soldin SJ. Tacrolimus metabolite cross-reactivity in different tacrolimus assays. Clin Biochem 1998;31:613-7.
23. Liu WT, Ren Y, Wang J, Eng RT, Wong PY. The detection of tacrolimus and its metabolites, in whole blood of transplant patients by an improved HPLC-Abbott tacrolimus II immunoassay. J Clin Ligand Assay 1998;21:68-75.
24. Webb NJA, Stevenson PJ, Lewis MA, Postlethwaite RJ, Bradbury MG, Undre NA. Pharmacokinetics of tacrolimus in pediatric renal transplant recipients. Transplant Proc 2002;34:1948-50.
25. Gonischior AK, Christians U, Winkler M, Linck A, Baumann J, Sewing K-F. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients. Clin Chem 1996;42:1426-62.